GreenLight Biosciences Overview
- Founded
- 2008
- Status
- Public
- Employees
- 283
- Stock Symbol
- GRNA
- Share Price
- $5.82
- (As of Monday Closing)
GreenLight Biosciences General Information
Description
GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.
Contact Information
Website
www.greenlightbiosciences.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Specialty Chemicals
Stock Exchange
NAS
Primary Office
- 200 Boston Avenue
- Suite 1000
- Medford, MA 02155
- United States
+1 (888) 000-0000
GreenLight Biosciences Timeline
GreenLight Biosciences Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.82 | $4.92 | $4.83 - $15.80 | $604M | 123M | 315K | -$0.92 |
GreenLight Biosciences Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|
| Revenue | 0 | 962 | 3,001 |
| EBITDA | (89,067) | (50,552) | (28,509) |
| Net Income | (95,126) | (53,251) | (28,649) |
| Total Assets | 63,292 | 113,828 | 30,609 |
| Total Debt | 38,816 | 18,898 | 1,572 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
GreenLight Biosciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.
Request a free trialGreenLight Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.
Request a free trialGreenLight Biosciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
GreenLight Biosciences Inc is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic
Biotechnology
Medford, MA
283
As of 2022
00000
000000000
00000
000000
um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000000000000
Seattle, WA
00
As of 0000
000.00
0000000000 0
000.00
000 0000
ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehe
000000000 000000000
Boulder, CO
00
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGreenLight Biosciences Competitors (16)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arzeda | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000 00000000000000 | Venture Capital-Backed | Boulder, CO | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Lutherville Timonium, MD | 0 | 000.00 | 0000000000 0 | 000.00 |
| 0000000 | Formerly VC-backed | Lebanon, NH | 00 | 000.00 | 000000&0 | 000.00 |
| 0000000 | Corporation | Roslin, United Kingdom | 0 | 0000000000 |
GreenLight Biosciences Patents
GreenLight Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210068402-A1 | Methods and compositions for control of arthropod pests | Pending | 05-Sep-2019 | 0000000000 | |
| CA-3135368-A1 | Cell-free production of ribonucleic acid | Pending | 29-Mar-2019 | 0000000000 | |
| AU-2020253354-A1 | Cell-free production of ribonucleic acid | Pending | 29-Mar-2019 | 0000000000 | |
| EP-3899006-A2 | Cell-free production of allulose | Pending | 21-Dec-2018 | 00000000 | |
| CA-3123590-A1 | Cell-free production of allulose | Pending | 21-Dec-2018 | C07H3/02 |
GreenLight Biosciences Executive Team (10)
GreenLight Biosciences Board Members (19)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrey Zarur Ph.D | GreenLight Biosciences | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Charles Cooney Ph.D | Self | Board Member | 000 0000 |
| Colin Steen | Syngenta Group Ventures | Board Member | 000 0000 |
| David Furneaux | Kodiak Venture Partners | Board Member | 000 0000 |
| Eric O'Brien | Fall Line Capital | Board Member | 000 0000 |
GreenLight Biosciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGreenLight Biosciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore GreenLight Biosciences‘s full profile, request access.
Request a free trial